For patients with non-valvular atrial fibrillation and no history of GI bleed, is apixaban 2.5mg po bid a reasonable alternative to warfarin target INR 2-3?
Hello,
The data are very limited in this group as you know. We have been using DOACs in our dialysis patients but clearly it is without ironclad evidence and support.
I believe that future clinical trials will be very helpful in clarifying this point but until then it is definitely a judgement call.
Dr. Jordan Weinstein
The data are very limited in this group as you know. We have been using DOACs in our dialysis patients but clearly it is without ironclad evidence and support.
I believe that future clinical trials will be very helpful in clarifying this point but until then it is definitely a judgement call.
Dr. Jordan Weinstein
- Page :
- 1
There are no replies made for this post yet.
